Toviaz

Product NDC: 0069-0244
11-digit product format: 000690244
Labeler code: 0069
Product ID: 0069-0244_ca2031f1-5425-4d31-bf14-c865ec4e89b7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: fesoterodine fumarate
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Pfizer Laboratories Div Pfizer Inc
Application: NDA022030
Marketing category: NDA
Marketing start: 2008-10-31
Substance: FESOTERODINE FUMARATE
Active strength: 8 mg/1
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022030-001	TOVIAZ	FESOTERODINE FUMARATE	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31
N022030-002	TOVIAZ	FESOTERODINE FUMARATE	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N022030-001	AB
N022030-002	AB

Orange Book patents#

Current patent rows page 1 of 1 · 12 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N022030-001	7807715	2027-06-07	U-913	Drug product
N022030-001	8088398	2027-06-07	U-913	Drug product
N022030-001	8501723	2027-06-07		Drug product	2013-08-20
N022030-001	7807715*PED	2027-12-07		Pediatric extension
N022030-001	8088398*PED	2027-12-07		Pediatric extension
N022030-001	8501723*PED	2027-12-07		Pediatric extension
N022030-002	7807715	2027-06-07	U-913	Drug product
N022030-002	8088398	2027-06-07	U-913	Drug product
N022030-002	8501723	2027-06-07		Drug product	2013-08-20
N022030-002	7807715*PED	2027-12-07		Pediatric extension
N022030-002	8088398*PED	2027-12-07		Pediatric extension
N022030-002	8501723*PED	2027-12-07		Pediatric extension

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022030-001	TOVIAZ	4MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	2008-10-31	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N022030-002	TOVIAZ	8MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2008-10-31	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N022030-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022030-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022030-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022030-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022030-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022030-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022030-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022030-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022030-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022030-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022030-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022030-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022030-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022030-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022030-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022030-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022030-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022030-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022030-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022030-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022030-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022030-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022030-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022030-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022030-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022030-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022030-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022030-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022030-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N022030-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022030-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N022030-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022030-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022030-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022030-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N022030-002	AB	1	`bb7c543d1eb4…`

Observed Orange Book patent history#

Patent history page 1 of 14 · 556 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N022030-001	7807715	2027-06-07	U-913	Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-001	8088398	2027-06-07	U-913	Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-001	8501723	2027-06-07		Drug product	2013-08-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-001	7807715*PED	2027-12-07		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-001	8088398*PED	2027-12-07		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-001	8501723*PED	2027-12-07		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-002	7807715	2027-06-07	U-913	Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-002	8088398	2027-06-07	U-913	Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-002	8501723	2027-06-07		Drug product	2013-08-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-002	7807715*PED	2027-12-07		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-002	8088398*PED	2027-12-07		Pediatric extension		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022030-002	8501723*PED	2027-12-07		Pediatric extension		`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022030-001	7807715	2027-06-07	U-913	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-001	8088398	2027-06-07	U-913	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-001	8501723	2027-06-07		Drug product	2013-08-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-001	7807715*PED	2027-12-07		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-001	8088398*PED	2027-12-07		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-001	8501723*PED	2027-12-07		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-002	7807715	2027-06-07	U-913	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-002	8088398	2027-06-07	U-913	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-002	8501723	2027-06-07		Drug product	2013-08-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-002	7807715*PED	2027-12-07		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-002	8088398*PED	2027-12-07		Pediatric extension		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022030-002	8501723*PED	2027-12-07		Pediatric extension		`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-001	7807715	2027-06-07	U-913	Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-001	8088398	2027-06-07	U-913	Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-001	8501723	2027-06-07		Drug product	2013-08-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-001	7807715*PED	2027-12-07		Pediatric extension		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-001	8088398*PED	2027-12-07		Pediatric extension		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-001	8501723*PED	2027-12-07		Pediatric extension		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-002	7807715	2027-06-07	U-913	Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-002	8088398	2027-06-07	U-913	Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-002	8501723	2027-06-07		Drug product	2013-08-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-002	7807715*PED	2027-12-07		Pediatric extension		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-002	8088398*PED	2027-12-07		Pediatric extension		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022030-002	8501723*PED	2027-12-07		Pediatric extension		`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022030-001	7807715	2027-06-07	U-913	Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022030-001	8088398	2027-06-07	U-913	Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022030-001	8501723	2027-06-07		Drug product	2013-08-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022030-001	7807715*PED	2027-12-07		Pediatric extension		`6a471c1ec25d…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 3 · 108 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022030-001	I-861	2024-06-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022030-001	PED	2024-12-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022030-002	I-861	2024-06-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022030-002	PED	2024-12-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022030-001	I-861	2024-06-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022030-001	PED	2024-12-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022030-002	I-861	2024-06-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022030-002	PED	2024-12-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022030-001	I-861	2024-06-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022030-001	PED	2024-12-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022030-002	I-861	2024-06-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022030-002	PED	2024-12-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022030-001	I-861	2024-06-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022030-001	PED	2024-12-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022030-002	I-861	2024-06-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022030-002	PED	2024-12-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022030-001	I-861	2024-06-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022030-001	PED	2024-12-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022030-002	I-861	2024-06-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022030-002	PED	2024-12-17	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022030-001	I-861	2024-06-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022030-001	PED	2024-12-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022030-002	I-861	2024-06-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022030-002	PED	2024-12-17	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022030-001	I-861	2024-06-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022030-001	PED	2024-12-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022030-002	I-861	2024-06-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022030-002	PED	2024-12-17	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022030-001	I-861	2024-06-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022030-001	PED	2024-12-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022030-002	I-861	2024-06-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022030-002	PED	2024-12-17	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022030-001	I-861	2024-06-17	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022030-001	PED	2024-12-17	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022030-002	I-861	2024-06-17	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022030-002	PED	2024-12-17	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022030-001	I-861	2024-06-17	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022030-001	PED	2024-12-17	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022030-002	I-861	2024-06-17	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022030-002	PED	2024-12-17	`5c6f7cd8ea54…`

Additional Listing Data#

Finished product: Yes
Brand name base: Toviaz
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FESOTERODINE FUMARATE	8 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
EOS72165S7	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
810071	Internal RxNorm lookup
810075	Internal RxNorm lookup
810077	Internal RxNorm lookup
810079	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5be745f0-8ae7-4c3c-9962-37d6263326f1	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
929b9598-46e7-5b66-7a86-5544524fb173	Product name	6	20240208
351abe41-466c-4dd8-840a-0fdb68318bd5	Product name	1	20230316

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0069-0244-30	2024-01-30	C162847	48780-1	1030e365-5eae-111a-e063-dadaa90a10e2	These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. TOVIAZ ® (fesoterodine fumarate) extended-release tablets, for oral use Initial U.S. Approval: 2008

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0069-0244-30	Toviaz	30 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	30		33

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0069-0244-30	EA - Each	0069-0244	a599c5b3-b3c9-4935-b1d2-86976a660996	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
FESOTERODINE FUMARATE	ACTIVE INGREDIENT	EOS72165S7	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
FESOTERODINE	ACTIVE MOIETY	621G617227	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
GLYCERYL DIBEHENATE	INACTIVE INGREDIENT	R8WTH25YS2	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
INDIGOTINDISULFONATE SODIUM	INACTIVE INGREDIENT	D3741U8K7L	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
LECITHIN, SOYBEAN	INACTIVE INGREDIENT	1DI56QDM62	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
XYLITOL	INACTIVE INGREDIENT	VCQ006KQ1E	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	19
fesoterodine fumarate	ACTIVE INGREDIENT	EOS72165S7	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
fesoterodine	ACTIVE MOIETY	621G617227	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
aluminum oxide	INACTIVE INGREDIENT	LMI26O6933	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
glyceryl behenate	INACTIVE INGREDIENT	R8WTH25YS2	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
indigotindisulfonate sodium	INACTIVE INGREDIENT	D3741U8K7L	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
lecithin, soybean	INACTIVE INGREDIENT	1DI56QDM62	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
polyethylene glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
polyvinyl alcohol	INACTIVE INGREDIENT	532B59J990	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
talc	INACTIVE INGREDIENT	7SEV7J4R1U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
xylitol	INACTIVE INGREDIENT	VCQ006KQ1E	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	3
FESOTERODINE FUMARATE	ACTIVE INGREDIENT	EOS72165S7	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
FESOTERODINE	ACTIVE MOIETY	621G617227	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
GLYCERYL DIBEHENATE	INACTIVE INGREDIENT	R8WTH25YS2	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
INDIGOTINDISULFONATE SODIUM	INACTIVE INGREDIENT	D3741U8K7L	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
LECITHIN, SOYBEAN	INACTIVE INGREDIENT	1DI56QDM62	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
XYLITOL	INACTIVE INGREDIENT	VCQ006KQ1E	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0069-0244	TOVIAZ (FESOTERODINE FUMARATE) TABLET, FILM COATED, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC]	32	Current NDC, Legacy NDC, 1 package rows	20241215_5be745f0-8ae7-4c3c-9962-37d6263326f1.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Toviaz	FESOTERODINE FUMARATE	Pfizer Laboratories Div Pfizer Inc	5be745f0-8ae7-4c3c-9962-37d6263326f1	2026-04-07	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022030 application number: NDA022030 ndc (product): 0069-0244

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
EOS72165S7	FESOTERODINE FUMARATE	286930-03-8	FESOTERODINE FUMARATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
810071	fesoterodine fumarate 4 MG 24HR Extended Release Oral Tablet	PSN	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810077	fesoterodine fumarate 8 MG 24HR Extended Release Oral Tablet	PSN	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810075	Toviaz 4 MG 24HR Extended Release Oral Tablet	PSN	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810079	Toviaz 8 MG 24HR Extended Release Oral Tablet	PSN	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810075	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet [Toviaz]	SBD	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810079	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz]	SBD	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810071	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet	SCD	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810077	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet	SCD	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810075	24 HR Toviaz 4 MG Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810079	24 HR Toviaz 8 MG Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810071	fesoterodine fumarate 4 MG 24 HR Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810077	fesoterodine fumarate 8 MG 24 HR Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810075	Toviaz 4 MG 24 HR Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810079	Toviaz 8 MG 24 HR Extended Release Oral Tablet	SY	5be745f0-8ae7-4c3c-9962-37d6263326f1	33
810071	fesoterodine fumarate 4 MG 24HR Extended Release Oral Tablet	PSN	fead426f-b955-4b41-8553-f102d17afa3a	3
810077	fesoterodine fumarate 8 MG 24HR Extended Release Oral Tablet	PSN	fead426f-b955-4b41-8553-f102d17afa3a	3
810075	Toviaz 4 MG 24HR Extended Release Oral Tablet	PSN	fead426f-b955-4b41-8553-f102d17afa3a	3
810079	Toviaz 8 MG 24HR Extended Release Oral Tablet	PSN	fead426f-b955-4b41-8553-f102d17afa3a	3
810075	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet [Toviaz]	SBD	fead426f-b955-4b41-8553-f102d17afa3a	3
810079	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz]	SBD	fead426f-b955-4b41-8553-f102d17afa3a	3
810071	24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet	SCD	fead426f-b955-4b41-8553-f102d17afa3a	3
810077	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet	SCD	fead426f-b955-4b41-8553-f102d17afa3a	3
810075	24 HR Toviaz 4 MG Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810079	24 HR Toviaz 8 MG Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810071	fesoterodine fumarate 4 MG 24 HR Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810077	fesoterodine fumarate 8 MG 24 HR Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810075	Toviaz 4 MG 24 HR Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810079	Toviaz 8 MG 24 HR Extended Release Oral Tablet	SY	fead426f-b955-4b41-8553-f102d17afa3a	3
810077	fesoterodine fumarate 8 MG 24HR Extended Release Oral Tablet	PSN	e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26	1
810079	Toviaz 8 MG 24HR Extended Release Oral Tablet	PSN	e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26	1
810079	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet [Toviaz]	SBD	e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26	1
810077	24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet	SCD	e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26	1
810079	24 HR Toviaz 8 MG Extended Release Oral Tablet	SY	e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26	1
810077	fesoterodine fumarate 8 MG 24 HR Extended Release Oral Tablet	SY	e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26	1
810079	Toviaz 8 MG 24 HR Extended Release Oral Tablet	SY	e44e0f9d-6ff7-4a3d-995a-a2768bf9ac26	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0069-0244-30	00069024430	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0244-30)	2008-10-31	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Toviaz	Pfizer Laboratories Div Pfizer Inc \| Pfizer Ireland Pharmaceuticals Unlimited Company \| Pfizer Manufacturing Deutschland GmbH	2026-04-07	HUMAN PRESCRIPTION DRUG LABEL	33
Toviaz	Cardinal Health	2019-11-26	HUMAN PRESCRIPTION DRUG LABEL	6
Toviaz - Avera McKennan Hospital	Avera McKennan Hospital	2017-03-15	HUMAN PRESCRIPTION DRUG LABEL	1
Toviaz - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2012-04-06	HUMAN PRESCRIPTION DRUG LABEL	3